Jazz Pharmaceuticals ^Public

Jazz Pharmaceuticals is a specialty pharmaceutical company that focuses on improving patients' lives by identifying, developing, and commercializing innovative treatments for neurology and psychiatry. Their products include Xyrem for narcolepsy, Cystadane for homocystinuria, and Antizol for poisoning. They are also working on late-stage product candidates such as Luvox CR for obsessive-compulsive disorder and JZP-6 for fibromyalgia syndrome. Jazz Pharmaceuticals is committed to establishing consensus treatment recommendations and empowering patients through innovative science and real-world evidence. They are a leader in neuroscience and strive to address unmet medical needs.